Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1982 Jun;76(2):299–304. doi: 10.1111/j.1476-5381.1982.tb09220.x

Stereochemical requirements for central and peripheral muscarinic and antimuscarinic activity of some acetylenic compounds related to oxotremorine.

R Dahlbom, D J Jenden, B Resul, B Ringdahl
PMCID: PMC2071785  PMID: 7093587

Abstract

1 The enantiomers of some analogues of the central muscarinic agent, oxotremorine, were prepared and investigated for tremorogenic and tremorolytic activity in intact mice and for muscarinic and antimuscarinic activity on the isolated ileum of the guinea-pig. 2 The R-isomers were more potent than the S-isomers both in vivo and in vitro regardless of whether the compounds are agonists, partial agonists or competitive antagonists. 3 It is suggested that in the oxotremorine series, agonists and antagonists interact with a common receptor site, in contrast to classical muscarinic antagonists which are believed to bind also to accessory receptor areas, located close to the agonist binding site.

Full text

PDF
299

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ariens E. J., Simonis A. M. Cholinergic and anticholinergic drugs, do they act on common receptors? Ann N Y Acad Sci. 1967 Oct 31;144(2):842–869. doi: 10.1111/j.1749-6632.1967.tb53815.x. [DOI] [PubMed] [Google Scholar]
  3. BEBBINGTON A., SHAKESHAFT D. AN IMPROVED SYNTHESIS OF OXOTREMORINE. J Med Chem. 1965 Mar;8:274–275. doi: 10.1021/jm00326a037. [DOI] [PubMed] [Google Scholar]
  4. Barlow R. B., Casy A. F. Inversion of stereospecificity by methylation of compounds acting at acetylcholine receptors. Mol Pharmacol. 1975 Sep;11(5):690–693. [PubMed] [Google Scholar]
  5. Bebbington A., Brimblecombe R. W., Shakeshaft D. The central and peripheral activity of acetylenic amines related to oxotremorine. Br J Pharmacol Chemother. 1966 Jan;26(1):56–67. doi: 10.1111/j.1476-5381.1966.tb01811.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brimblecombe R. W., Rowsell D. G. A comparison of the pharmacological activities of tertiary bases and their quaternary ammonium derivatives. Int J Neuropharmacol. 1969 Mar;8(2):131–141. doi: 10.1016/0028-3908(69)90006-9. [DOI] [PubMed] [Google Scholar]
  7. Casy A. F. Stereochemical aspects of parasympathomimetics and their antagonists: recent developments. Prog Med Chem. 1975;11:1–65. doi: 10.1016/s0079-6468(08)70207-8. [DOI] [PubMed] [Google Scholar]
  8. Cho A. K., Jenden D. J., Lamb S. I. Rates of alkaline hydrolysis and muscarinic activity of some aminoacetates and their quaternary ammonium analogs. J Med Chem. 1972 Apr;15(4):391–394. doi: 10.1021/jm00274a016. [DOI] [PubMed] [Google Scholar]
  9. Dahlbom R., Lindquist A., Lindgren S., Svensson U., Ringdahl B., Blair M. R., Jr Stereospecificity of oxotremorine antagonists. Experientia. 1974 Oct 15;30(10):1165–1167. doi: 10.1007/BF01923668. [DOI] [PubMed] [Google Scholar]
  10. Ellenbroek B. W., Nivard R. J., van Rossum J. M., Ariëns E. J. Absolute configuration and parasympathetic action: pharmacodynamics of enantiomorphic and diastereoisomeric esters of beta-methylcholine. J Pharm Pharmacol. 1965 Jul;17(7):393–404. doi: 10.1111/j.2042-7158.1965.tb07694.x. [DOI] [PubMed] [Google Scholar]
  11. Hanin I., Jenden D. J., Cho A. K. The influence of pH on the muscarinic action of oxotremorine, arecoline, pilocarpine, and their quaternary ammonium analogs. Mol Pharmacol. 1966 Jul;2(4):352–359. [PubMed] [Google Scholar]
  12. Inch T. D., Brimblecombe R. W. Antiacetylcholine drugs: chemistry, stereochemistry, and pharmacology. Int Rev Neurobiol. 1974;16(0):67–144. doi: 10.1016/s0074-7742(08)60195-6. [DOI] [PubMed] [Google Scholar]
  13. Lindgren S., Lindquist A., Lindeke B., Svensson U., Karlén B., Dahlbom R. Acetylene compounds of potential pharmacological value. 18. N-(t-aminoalkynyl)-substituted 2-pyrrolidones, a new series of potent oxotremorine antagonists. Acta Pharm Suec. 1973 Dec;10(6):435–440. [PubMed] [Google Scholar]
  14. Rehavi M., Maayani S., Sokolovsky M. Enzymatic resolution and cholinergic properties of (+/-)3-quinuclidinol derivatives. Life Sci. 1977 Nov 1;21(9):1293–1302. doi: 10.1016/0024-3205(77)90010-8. [DOI] [PubMed] [Google Scholar]
  15. Resul B., Ringdahl B., Dahlbom R. Acetylene compounds of potential pharmacological value. XXX. Synthesis and pharmacological properties of N-(4-pyrrolidino-2-pentynyl)-substituted 2-pyrrolidone and succinimide. Acta Pharm Suec. 1979;16(3):161–165. [PubMed] [Google Scholar]
  16. Ringdahl B., Dahlbom R. Acetylene compounds of potential pharmacological value. XXIX. Stereoselectivity of N-(1-alkyl-4-pyrrolidino-2-butynyl)-substituted 2-pyrrolidones and succinimides as oxotremorine antagonists. Acta Pharm Suec. 1979;16(1):13–20. [PubMed] [Google Scholar]
  17. Ringdahl B., Dahlbom R. Stereoselectivity of oxotremorine antagonists containing a chiral pyrrolidine group. Experientia. 1978 Oct 15;34(10):1334–1335. doi: 10.1007/BF01981455. [DOI] [PubMed] [Google Scholar]
  18. Ringdahl B., Muhi-Eldeen Z., Ljunggren C., Karlén B., Resul B., Dahlbom R. Acetylene compounds of potential pharmacological value. XXVIII. Oxotremorine analogues substituted with a methyl group in the lactam ring. Acta Pharm Suec. 1979;16(2):89–94. [PubMed] [Google Scholar]
  19. Ringdahl B., Resul B., Dahlbom R. Stereoselectivity of some oxotremorine antagonists containing two chiral centres. J Pharm Pharmacol. 1979 Dec;31(12):837–839. doi: 10.1111/j.2042-7158.1979.tb13676.x. [DOI] [PubMed] [Google Scholar]
  20. Svensson U., Dahlbom R. Acetylene compounds of potential pharmacological value. XIX. N-(dialkylaminoalkynyl)-substituted succinimides and 2-pyrrolidones as partial cholinergic agonists. Acta Pharm Suec. 1975;12(3):209–214. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES